Ming Chu
Impact in
- Pharmacology top 5%
- Berberine and alkaloids research
- Alkaloids: synthesis and pharmacology
- Pharmacological Effects of Natural Compounds
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Glycosylation and Glycoproteins Research 4
- Oncology 12
- Cytokine Signaling Pathways and Interactions 3
- Cancer-related Molecular Pathways 3
- Co-authors
- Zheng-yun Chu (8 shared papers)Yuedan Wang (12 shared papers)Mingbo Zhang (3 shared papers)Yimiao Zhu (1 shared paper)Zhou Zhou (1 shared paper)Ran Ding (2 shared papers)Yuedan Wang (11 shared papers)Lan Xu (2 shared papers)
- Journals
- Frontiers in Pharmacology (5 papers)Frontiers in Immunology (3 papers)PLoS ONE (3 papers)Frontiers in Oncology (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesRussia
In The Last Decade
Ming Chu
49 papers receiving 849 citations
Peers
Comparison fields: 5 of 114
- Pharmacology 109
- Pharmacology 181
- Molecular Medicine 49
- Immunology 124
- Periodontics 24
Countries citing papers authored by Ming Chu
This map shows the geographic impact of Ming Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Chu more than expected).
Fields of papers citing papers by Ming Chu
This network shows the impact of papers produced by Ming Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Chu. The network helps show where Ming Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 105 | |
| 2 | 2014 | 90 | |
| 3 | 2017 | 82 | |
| 4 | 2015 | 71 | |
| 5 | 2022 | 65 | |
| 6 | 2015 | 43 | |
| 7 | 2018 | 30 | |
| 8 | 2018 | 29 | |
| 9 | 2013 | 28 | |
| 10 | 2000 | 26 | |
| 11 | 2022 | 23 | |
| 12 | 2008 | 20 | |
| 13 | 2023 | 18 | |
| 14 | 2022 | 18 | |
| 15 | 2022 | 17 | |
| 16 | 2022 | 12 | |
| 17 | [Effect of baicalin on in vivo anti-virus]. | 2007 | 12 |
| 18 | [The extract of compound Radix Scutellariae on mRNA replication and IFN expression of influenza virus in mice]. | 2007 | 12 |
| 19 | 2022 | 10 | |
| 20 | 2022 | 10 |
About Ming Chu
Ming Chu is a scholar working on Molecular Biology, Oncology, Immunology, Pharmacology and Infectious Diseases, having authored 52 papers that have together received 867 indexed citations. Recurring topics across this work include Berberine and alkaloids research (5 papers), Glycosylation and Glycoproteins Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), IL-33, ST2, and ILC Pathways (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Immune Response and Inflammation (3 papers), Dermatology and Skin Diseases (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Pharmacology (109 citations), Pharmacology (181 citations), Molecular Medicine (49 citations), Immunology (124 citations) and Periodontics (24 citations). Ming Chu has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Zheng-yun Chu, Yuedan Wang, Mingbo Zhang, Yimiao Zhu, Zhou Zhou, Ran Ding, Yuedan Wang, Lan Xu, Mingbo Zhang and Kailin Yin. Their work appears in journals such as Frontiers in Pharmacology, Frontiers in Immunology, PLoS ONE, Frontiers in Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.